Beactica Therapeutics AB: Funding, Investors & Team (Sep 2026)
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Beactica’s approach is centered around targeting disease proteins with synthetic lethality vulnerabilities by applying its molecular interaction-based drug discovery engine to generate novel small molecule across synergistic modalities, including allosteric modulators and targeted protein degraders (PROTACs). Beactica deliver value to patients and shareholders by advancing its programmes into early clinical trials.
Beactica Therapeutics AB has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Feb 2026.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Beactica Therapeutics AB Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Beactica Therapeutics AB Funding Rounds
Beactica Therapeutics AB Founders and Leadership Team
No contact details are on record for this team yet.
Beactica Therapeutics AB Funding Compared to Other Health Care Startups
Beactica Therapeutics AB's latest round of $3.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Beactica Therapeutics AB in Health Care and Uppsala
Companies Similar to Beactica Therapeutics AB
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical…
Beactica Therapeutics AB Funding FAQs
What does Beactica Therapeutics AB do?
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Beactica’s approach is centered around targeting disease proteins with synthetic lethality vulnerabilities by applying its molecular interaction-based drug discovery engine to generate novel small molecule across synergistic modalities, including allosteric modulators and targeted protein degraders (PROTACs). Beactica deliver value to patients and shareholders by advancing its programmes into early clinical trials.
How much funding has Beactica Therapeutics AB raised?
Beactica Therapeutics AB has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Feb 2026.
When did Beactica Therapeutics AB last raise funding?
Beactica Therapeutics AB's most recent funding round on record is an undisclosed round of $3.0M, announced in Feb 2026.
Who founded Beactica Therapeutics AB?
FundedIQ lists Per Kallblad (Founder) at Beactica Therapeutics AB.
Where is Beactica Therapeutics AB headquartered?
Beactica Therapeutics AB is based in Uppsala, Uppsala Lan, Sweden.
How many employees does Beactica Therapeutics AB have?
Beactica Therapeutics AB is in the 11-50 employee band.
How does Beactica Therapeutics AB's funding compare to other Health Care startups?
Beactica Therapeutics AB's latest round of $3.0M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Beactica Therapeutics AB Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Beactica Therapeutics AB is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.